Nan Jiang

1.1k total citations
74 papers, 641 citations indexed

About

Nan Jiang is a scholar working on Rheumatology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Nan Jiang has authored 74 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 12 papers in Hematology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Nan Jiang's work include Systemic Lupus Erythematosus Research (25 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Renal Diseases and Glomerulopathies (7 papers). Nan Jiang is often cited by papers focused on Systemic Lupus Erythematosus Research (25 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Renal Diseases and Glomerulopathies (7 papers). Nan Jiang collaborates with scholars based in China, United States and Hong Kong. Nan Jiang's co-authors include Xiaofeng Zeng, Xinping Tian, Mengtao Li, Chanyuan Wu, Jiuliang Zhao, Qingfeng Wang, Yan Shi, Ji‐Ren An, Zeng Xiao-feng and Yan Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of the American College of Cardiology.

In The Last Decade

Nan Jiang

63 papers receiving 635 citations

Peers

Nan Jiang
Rosa Elena Navarro-Hernández Mexico
Ki‐Jo Kim South Korea
Evangelia Zampeli Greece
Stefan Zöllner Germany
Pierangelo Papaleo Italy
Yansong Li United States
Rosangela Lattanzio Italy
Franz Heigl Germany
Bomi Kim South Korea
Rosa Elena Navarro-Hernández Mexico
Nan Jiang
Citations per year, relative to Nan Jiang Nan Jiang (= 1×) peers Rosa Elena Navarro-Hernández

Countries citing papers authored by Nan Jiang

Since Specialization
Citations

This map shows the geographic impact of Nan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Jiang more than expected).

Fields of papers citing papers by Nan Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Jiang. The network helps show where Nan Jiang may publish in the future.

Co-authorship network of co-authors of Nan Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Jiang. A scholar is included among the top collaborators of Nan Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Jiang. Nan Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gui, Bin, et al.. (2025). Ultrasound-Responsive Nanobubbles for Breast Cancer: Synergistic Sonodynamic, Chemotherapy, and Immune Activation through the cGAS-STING Pathway. ACS Applied Materials & Interfaces. 17(13). 19317–19334. 12 indexed citations
2.
3.
Jia, Xiao, Zhao Cui, Xiaojuan Yu, et al.. (2025). Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease. Nephrology Dialysis Transplantation. 41(1). 55–66. 1 indexed citations
4.
Zhou, Yaping, Min Shen, Nan Jiang, et al.. (2025). Decoding neurovascular signatures: advanced imaging insights in DADA2-Related Cerebral Microangiopathy. Neurological Sciences. 47(1). 18–18.
5.
6.
Jiang, Nan, Shangyi Jin, Yú Chen, et al.. (2023). Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis. Frontiers in Immunology. 14. 1232244–1232244. 6 indexed citations
7.
8.
Geng, Chang, Zhijun Wang, Jin Wu, et al.. (2023). Acute necrotizing encephalopathy associated with COVID-19: case series and systematic review. Journal of Neurology. 270(11). 5171–5181. 8 indexed citations
9.
Jiang, Nan, Can Huang, Shuang Zhou, et al.. (2023). Mortality and prognostic factors in connective tissue disease‐associated pulmonary arterial hypertension patients complicated with right heart failure. International Journal of Rheumatic Diseases. 26(5). 862–869. 7 indexed citations
10.
Xu, Dong, Qian Wang, Mengtao Li, et al.. (2023). Predictors and prognosis of tracheostomy in relapsing polychondritis. Lara D. Veeken. 63(11). 3042–3049.
11.
Zhang, Lifan, X. Zou, Nan Jiang, et al.. (2023). Incidence and risk factors of tuberculosis in systemic lupus erythematosus patients: a multi-center prospective cohort study. Frontiers in Immunology. 14. 1157157–1157157. 7 indexed citations
12.
Tian, Xinping, Mengtao Li, Nan Jiang, et al.. (2023). Comparative Efficacy of Secukinumab Versus Tumor Necrosis Factor Inhibitors for the Treatment of Takayasu Arteritis. Arthritis & Rheumatology. 75(8). 1415–1423. 17 indexed citations
13.
Li, Jingna, Di Wu, Yunjiao Yang, et al.. (2023). B cell repopulation trajectory after rituximab treatment in autoimmune diseases: a longitudinal observational study. Clinical and Experimental Medicine. 23(8). 4787–4795. 2 indexed citations
14.
Jiang, Nan, et al.. (2022). Multi-Scale Graph-Based Feature Fusion for Few-Shot Remote Sensing Image Scene Classification. Remote Sensing. 14(21). 5550–5550. 11 indexed citations
15.
Jiang, Nan, Qin Li, Hongbin Li, et al.. (2022). Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients. Chinese Medical Journal. 135(18). 2210–2217. 7 indexed citations
16.
17.
Yang, Yujiao, Junke Song, Shan Liu, et al.. (2021). Salvianolic acid A relieves cognitive disorder after chronic cerebral ischemia: Involvement of Drd2/Cryab/NF-κB pathway. Pharmacological Research. 175. 105989–105989. 42 indexed citations
18.
Li, Hongbin, Xinwang Duan, Yongfei Fang, et al.. (2020). Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow‐ups and predictors of achieving treatment target. International Journal of Rheumatic Diseases. 23(12). 1719–1727. 5 indexed citations
19.
Chen, Yu, Min Li, Xinwang Duan, et al.. (2018). Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis.. PubMed. 36(5). 836–840. 32 indexed citations
20.
Jiang, Nan. (2011). Attitude Algorithm Design of AHRS Based on Kalman Filter. Chuangan jishu xuebao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Elena Navarro-Hernández Breakdown of academic impact, for papers by Ki‐Jo Kim Breakdown of academic impact, for papers by Evangelia Zampeli Breakdown of academic impact, for papers by Stefan Zöllner Breakdown of academic impact, for papers by Pierangelo Papaleo Breakdown of academic impact, for papers by Yansong Li Breakdown of academic impact, for papers by Rosangela Lattanzio Breakdown of academic impact, for papers by Franz Heigl Breakdown of academic impact, for papers by Bomi Kim
Rankless by CCL
2026